INL works to keep Americans safe at home by countering international crime, illegal drugs, and instability abroad. INL helps countries deliver justice and fairness by strengthening their police, courts, and corrections systems. These efforts reduce the amount of crime and illegal drugs reaching U.S. shores.
This month on November 9th, 2022, the International Narcotics and Law Enforcement Affairs (INL) DDR Partners meeting offered a discussion on quality assurance and included two presentations:
Presented as part of the Uniting the global community to face the challenge of addiction event, online, on 13th May, 2022
Partner Profile INL
Partner Profiles
Our partners introduce their missions, programs, and resources to support the workforce and activities.
The U.S. Department of State's Bureau of International Narcotics and Law Enforcement Affairs (INL) presents the third annual event on partnering with the private sector to address the world drug problem.
The private sector can play a major role in preventing and combating the manufacture, diversion, sale, and misuse of drugs and precursors by mobilizing its unique resources, technologies, and expertise.
The U.S. Department of State's Bureau of International Narcotics and Law Enforcement Affairs (INL) presents the third annual event on partnering with the private sector to address the world drug problem.
The private sector can play a major role in preventing and combating the manufacture, diversion, sale, and misuse of drugs and precursors by mobilizing its unique resources, technologies, and expertise.
The U.S. Department of State's Bureau of International Narcotics and Law Enforcement Affairs (INL) presents the third annual event on partnering with the private sector to address the world drug problem.
The private sector can play a major role in preventing and combating the manufacture, diversion, sale, and misuse of drugs and precursors by mobilizing its unique resources, technologies, and expertise.
Substance use disorders are reoccurring chronic, often relapsing disease that affect the brain and should be treated within the public health arena similar to other diseases such as diabetes and heart disease. This understanding, however, does not easily find its way into public or social policy.
2021 INCSR–Volume I: Drug and Chemical Control (As submitted to Congress)
To read the full report, please visit: https://www.state.gov/2021-incsr-volume-i-drug-and-chemical-control-as-submitted-to-congress/